Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine- and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients
- PMID: 20881176
- PMCID: PMC3008443
- DOI: 10.1128/JCM.01518-10
Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine- and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients
Abstract
We aimed to study the prevalence and clinical implications of hepatitis B virus (HBV) subgenotypes in Chinese patients. A total of 4,300 patients, mainly from northern China, were enrolled, including 182 patients with acute hepatitis B and 4,118 patients with chronic HBV infection who had been exposed to nucleoside or nucleotide analogs. HBV genotypes/subgenotypes were determined by direct sequencing of the HBV S/Pol region. The prevalence rates were 0.40% for HBV/B1, 14.30% for HBV/B2, 0.25% for HBV/B3, 0.35% for HBV/B4, 1.05% for HBV/C1, 81.72% for HBV/C2, 0.93% for HBV/C3, 0.16% for HBV/C4, and 0.84% for HBV/D. In chronic HBV infection, patients with HBV/B2 were younger and had lower ΗBeAg positive rates than patients with HBV/C2. The incidence of lamivudine-resistant mutations was significantly higher in HBV/C2 compared to HBV/B2 (27.9% versus 19.8%; P<0.01), and the significant difference was observed only for rtM204I and not rtM204V. In addition, compensatory mutations were more frequently detected in HBV/C2. The incidence of adefovir-resistant mutations was similar between the two subsets, but HBV/C2 inclined to show rtA181V (3.6% for C2 versus 0.9% for B2; P<0.01), while HBV/B2 inclined to show rtN236T (4.5% for versus 2.5% for C2; P<0.01). The ratios of HBV/B2 to HBV/C2 infection were 1.7 (110/65), 5.7 (2,653/463), 7.5 (520/69), 8.0 (48/6), and 15.3 (183/12) for acute hepatitis B, chronic hepatitis B, liver cirrhosis, acute-on-chronic liver failure, and hepatocellular carcinoma, respectively. In conclusion, HBV/C2 and HBV/B2, two prevalent subgenotypes, differ in lamivudine- and adefovir-resistance-associated mutational patterns. HBV/C2-infected patients are more likely to have disease progression than HBV/B2-infected ones.
Figures
Similar articles
-
Association of lamivudine-resistant mutational patterns with the antiviral effect of adefovir in patients with chronic hepatitis B.J Med Virol. 2009 Mar;81(3):417-24. doi: 10.1002/jmv.21402. J Med Virol. 2009. PMID: 19152409
-
Acute hepatitis B infection associated with drug-resistant hepatitis B virus.J Clin Virol. 2010 Aug;48(4):270-4. doi: 10.1016/j.jcv.2010.05.010. Epub 2010 Jun 26. J Clin Virol. 2010. PMID: 20580309
-
Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.Antivir Ther. 2015;20(2):141-7. doi: 10.3851/IMP2813. Epub 2014 Jul 3. Antivir Ther. 2015. PMID: 24992206
-
Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern.J Med Virol. 2010 Nov;82(11):1850-8. doi: 10.1002/jmv.21902. J Med Virol. 2010. PMID: 20872711 Review.
-
Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.Antivir Chem Chemother. 2001 Jan;12(1):1-35. doi: 10.1177/095632020101200101. Antivir Chem Chemother. 2001. PMID: 11437320 Review.
Cited by
-
Variability in the Responses of Hepatitis B Virus D-Subgenotypes to Antiviral Therapy: Designing Pan-D-Subgenotypic Reverse Transcriptase Inhibitors.J Virol. 2022 Jan 26;96(2):e0180021. doi: 10.1128/JVI.01800-21. Epub 2021 Nov 3. J Virol. 2022. PMID: 34730399 Free PMC article.
-
Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B.Hepatol Int. 2024 Apr;18(2):435-448. doi: 10.1007/s12072-023-10631-9. Epub 2024 Feb 20. Hepatol Int. 2024. PMID: 38376650 Free PMC article.
-
Genetic diversity, viraemic and aminotransferases levels in chronic infected hepatitis B patients from Cameroon.BMC Res Notes. 2016 Feb 22;9:117. doi: 10.1186/s13104-016-1916-7. BMC Res Notes. 2016. PMID: 26899506 Free PMC article.
-
Additional N-glycosylation mutation in the major hydrophilic region of hepatitis B virus S gene is a risk indicator for hepatocellular carcinoma occurrence in patients with coexistence of HBsAg/anti-HBs.Oncotarget. 2017 Jun 27;8(37):61719-61730. doi: 10.18632/oncotarget.18682. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977899 Free PMC article.
-
Binding sensitivity of adefovir to the polymerase from different genotypes of HBV: molecular modeling, docking and dynamics simulation studies.Acta Pharmacol Sin. 2013 Feb;34(2):319-28. doi: 10.1038/aps.2012.146. Epub 2012 Dec 3. Acta Pharmacol Sin. 2013. PMID: 23202802 Free PMC article.
References
-
- Allen, M. I., M. Deslauriers, C. W. Andrews, G. A. Tipples, K. A. Walters, D. L. Tyrrell, N. Brown, and L. D. Condreay. 1998. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology 27:1670-1677. - PubMed
-
- Angus, P., R. Vaughan, S. Xiong, H. Yang, W. Delaney, C. Gibbs, C. Brosgart, D. Colledge, R. Edwards, A. Ayres, A. Bartholomeusz, and S. Locarnini. 2003. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 125:292-297. - PubMed
-
- Borroto-Esoda, K., M. D. Miller, and S. Arterburn. 2007. Pooled analysis of amino acid changes in the HBV polymerase in patients from four major adefovir dipivoxil clinical trials. J. Hepatol. 47:492-498. - PubMed
-
- Buti, M., M. Cotrina, A. Valdes, R. Jardi, F. Rodriguez-Frias, and R. Esteban. 2002. Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine? J. Hepatol. 36:445-446. - PubMed
-
- Buti, M., F. Rodriguez-Frias, R. Jardi, and R. Esteban. 2005. Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypes. J. Clin. Virol. 34(Suppl. 1):S79-S82. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous